← Back to Search

Augmented Reality Exposure for Animal Phobia

N/A

Waitlist Available

Led By Arash Javanbakht, MD

Research Sponsored by Wayne State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in score from baseline to post treatment (immediately following the last exposure therapy session and at one-month follow-up)

Awards & highlights

Study Summary

This trial will test a new exposure therapy platform that uses augmented reality to expose patients with cynophobia to virtual dogs in the real world. The platform will include a software that allows the clinician to position virtual objects in the real environment of the patient. The investigators will then measure the impact of treatment and compare to before treatment measures of fear of the phobic object.

Who is the study for?

This trial is for individuals who have a strong fear of dogs (cynophobia) as their main issue, confirmed by DSM-5 criteria. Participants must be willing and able to consent to the study. It's not suitable for those with unstable behavior, visual or auditory disabilities that affect AR goggle use, seizure history, under court care, on certain medications like antidepressants or mood stabilizers, or with serious medical conditions.Check my eligibility

What is being tested?

The trial tests an augmented reality exposure therapy method for dog phobia using patented software and AR devices in a clinical setting. The patient undergoes guided exposure to virtual dogs in various forms while wearing AR goggles to reduce their fear response.See study design

What are the potential side effects?

Since this intervention involves psychological therapy rather than medication, side effects may include temporary increases in anxiety during early treatment sessions as part of the normal process of exposure therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in score on behavioral approach test from baseline to post treatment (immediately following the last exposure therapy session and at one-month follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in score on behavioral approach test from baseline to post treatment (immediately following the last exposure therapy session and at one-month follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in score on behavioral approach test from baseline to post treatment (immediately following the last exposure therapy session and at one-month follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Behavioral Approach Test--Ability to confront phobia

Secondary outcome measures

Cynophobia (fear of dogs) as measured by the Dog Phobia Questionnaire (DPQ)

Other outcome measures

Autonomic Arousal

Credibility and expectancy of treatment efficacy as measured by the Credibility/Expectancy Questionnaire

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

The experimental group will go through an exposure therapy session using an augmented reality headset device. The participant will work with the therapist, who will control the augmented reality paradigm and cater the exposure to the needs of the participant. The duration of the exposure will be as long as is needed to reduce anxiety regarding the feared object until self-reported subjective distress is low and stable.

Group II: Non-interventionActive Control1 Intervention

The control group will not go through an exposure therapy session using an augmented reality headset device. This will be a no-intervention control group that can have some form of exposure therapy following the conclusion of the treatment/research period.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor

307 Previous Clinical Trials

108,433 Total Patients Enrolled

Arash Javanbakht, MDPrincipal InvestigatorWayne State University

2 Previous Clinical Trials

154 Total Patients Enrolled

Media Library

Augmented reality exposure therapy Clinical Trial Eligibility Overview. Trial Name: NCT05067491 — N/A

Augmented reality exposure therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05067491 — N/A

Animal Phobia Research Study Groups: Intervention, Non-intervention

Animal Phobia Clinical Trial 2023: Augmented reality exposure therapy Highlights & Side Effects. Trial Name: NCT05067491 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I be a potential participant in this research endeavor?

"To be eligible for the research, patients must possess claustrophobia and reside in between 18 to 45 years of age. The capacity is nearly 40 individuals."

Answered by AI

How many individuals are enrolled in the research project?

"Affirmative. According to the clinicaltrials.gov website, this study is still available and searching for recruits. It was first published on August 18th 2022 and has since been updated on August 3rd of the same year. The trial hopes to enrol 40 patients from one medical center."

Answered by AI

Are there any openings in this experiment that can be filled by potential participants?

"Affirmative. According to clinicaltrials.gov, this medical research project initiated recruiting on August 18th 2022 and had its latest revision on the 3rd of August 2022. The study requires 40 volunteers from 1 site."

Answered by AI

Are the elderly within the accepted age range for this trial?

"To be a part of this medical trial, applicants must fit the age criteria which range from 18 to 45. For those that do not meet these requirements, there are alternative studies available for minors and seniors respectively with 2 and 4 trials being offered."

Answered by AI